• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中的免疫浸润及其临床价值:基于 TCGA 和 GEO 数据库的综合研究。

The Immune Infiltration in HNSCC and Its Clinical Value: A Comprehensive Study Based on the TCGA and GEO Databases.

机构信息

Heilongjiang University of Chinese Medicine, China.

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, China.

出版信息

Comput Math Methods Med. 2021 Nov 8;2021:1163250. doi: 10.1155/2021/1163250. eCollection 2021.

DOI:10.1155/2021/1163250
PMID:34790249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8592751/
Abstract

BACKGROUND

Being potential field of research for tumor immunological therapy, the head and neck squamous cell carcinoma (HNSCC) is one of most discussed types of tumor. Recently, some clinical trials have also used immunological therapy and demonstrated a subset of HNSCC patients who have shown a clear longer survival time.

OBJECTIVE

To conduct further studies and deeper research in the immunological oncology of HNSCC, a more detailed description and comprehending of the complicated landscape of immune infiltrative may be required.

METHODS

Firstly, we have described the fraction of different infiltrating immune cells in the HNSCC tumor and then compared it to the normal tissue, and secondly, we have explored the clinical implications of various infiltrated immune cell fractions meticulously. The gene expression profiles of HNSCC tissue were obtained from databases of TCGA and GEO and utilized the deconvolution algorithm (CIBERSORT) to presume the fractions of 22 several immune sensitive cells.

RESULTS

Our results indicated that the immune infiltrating cell fractions were considerably different between HNSCC tumor tissue and paired normal tissue, but at the same time, we found a potential internal correlation among the immune cells and also showed the association between immune infiltrating cells and their clinical characteristics. It is worth noting that the resting dendritic cells and M1 macrophages were linked with a favorable prognosis, while the CD4+ T cells with a poorer outcome.

CONCLUSION

Fractions of immune cell percentage were also associated with tumors' pathological grade, age, and TNM stage.

摘要

背景

头颈部鳞状细胞癌(HNSCC)是最常讨论的肿瘤类型之一,是肿瘤免疫治疗的潜在研究领域。最近,一些临床试验也使用了免疫疗法,并证明了一部分 HNSCC 患者的生存时间明显延长。

目的

为了对头颈部鳞状细胞癌的免疫肿瘤学进行进一步的研究和深入研究,可能需要更详细地描述和理解免疫浸润的复杂景观。

方法

首先,我们描述了 HNSCC 肿瘤中不同浸润免疫细胞的分数,然后将其与正常组织进行比较;其次,我们详细探讨了各种浸润免疫细胞分数的临床意义。从 TCGA 和 GEO 的数据库中获取 HNSCC 组织的基因表达谱,并利用去卷积算法(CIBERSORT)来推测 22 种免疫敏感细胞的分数。

结果

我们的结果表明,HNSCC 肿瘤组织和配对正常组织之间的免疫浸润细胞分数有很大差异,但同时,我们发现免疫细胞之间存在潜在的内在相关性,并显示了免疫浸润细胞与临床特征之间的关联。值得注意的是,静止树突状细胞和 M1 巨噬细胞与预后良好相关,而 CD4+T 细胞则与预后较差相关。

结论

免疫细胞百分比的分数也与肿瘤的病理分级、年龄和 TNM 分期有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/0ceb88cae502/CMMM2021-1163250.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/a565c4c7f960/CMMM2021-1163250.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/3a00dc3b7dec/CMMM2021-1163250.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/8bed3a19ca5a/CMMM2021-1163250.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/0ceb88cae502/CMMM2021-1163250.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/a565c4c7f960/CMMM2021-1163250.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/3a00dc3b7dec/CMMM2021-1163250.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/8bed3a19ca5a/CMMM2021-1163250.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/8592751/0ceb88cae502/CMMM2021-1163250.004.jpg

相似文献

1
The Immune Infiltration in HNSCC and Its Clinical Value: A Comprehensive Study Based on the TCGA and GEO Databases.头颈部鳞状细胞癌中的免疫浸润及其临床价值:基于 TCGA 和 GEO 数据库的综合研究。
Comput Math Methods Med. 2021 Nov 8;2021:1163250. doi: 10.1155/2021/1163250. eCollection 2021.
2
Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.头颈部癌中的肿瘤突变负担、免疫细胞浸润和免疫相关基因预后模型的构建。
Int J Med Sci. 2021 Jan 1;18(1):226-238. doi: 10.7150/ijms.51064. eCollection 2021.
3
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.全面分析头颈部鳞状细胞癌肿瘤微环境中的免疫细胞浸润。
Sci Rep. 2021 Aug 9;11(1):16134. doi: 10.1038/s41598-021-95718-9.
4
CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.CELSR3 是 HNSCC 的预后标志物,与肿瘤微环境中的免疫细胞浸润相关。
Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3143-3156. doi: 10.1007/s00405-024-08566-4. Epub 2024 Mar 20.
5
High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status.在头颈部鳞状细胞癌中,CLEC10A 的高表达预示着良好的预后和高水平的免疫浸润状态。
Cell Immunol. 2022 Feb;372:104472. doi: 10.1016/j.cellimm.2021.104472. Epub 2021 Dec 22.
6
Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.开发和验证十四对固有免疫相关基因对预测头颈部鳞状细胞癌预后的标志。
BMC Cancer. 2020 Oct 20;20(1):1015. doi: 10.1186/s12885-020-07489-7.
7
Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.建立和验证免疫微环境基因特征,以预测头颈部鳞状细胞癌患者的预后。
Int Immunopharmacol. 2021 Aug;97:107817. doi: 10.1016/j.intimp.2021.107817. Epub 2021 Jun 4.
8
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.TMB 的预后价值及 TMB 与头颈部鳞状细胞癌免疫浸润的关系:基于基因表达的研究。
Oral Oncol. 2020 Nov;110:104943. doi: 10.1016/j.oraloncology.2020.104943. Epub 2020 Sep 9.
9
Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma.关于 E2Fs 与人头颈部鳞状细胞癌预后和免疫浸润相关性的综合综述。
Asian J Surg. 2024 May;47(5):2106-2121. doi: 10.1016/j.asjsur.2024.01.130. Epub 2024 Feb 5.
10
SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.SLC13A4 可能作为一种预后生物标志物,并与头颈部鳞状细胞癌的免疫浸润相关。
Pathol Oncol Res. 2021 Nov 10;27:1609967. doi: 10.3389/pore.2021.1609967. eCollection 2021.

引用本文的文献

1
Identification and analysis of immune cell-related genes in cutaneous squamous cell carcinoma and drug network prediction.皮肤鳞状细胞癌中免疫细胞相关基因的鉴定与分析及药物网络预测
Arch Dermatol Res. 2024 Dec 30;317(1):158. doi: 10.1007/s00403-024-03587-9.
2
CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.在具有免疫活性的体内头颈部鳞状细胞癌模型中,CHMP2A调节广泛的免疫细胞介导的抗肿瘤活性。
J Immunother Cancer. 2024 May 3;12(5):e007187. doi: 10.1136/jitc-2023-007187.
3
Exploring the Expression of BCAS3 in Head and Neck Squamous Cell Carcinoma and Its Association With Prognosis.

本文引用的文献

1
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).纳武利尤单抗对比研究者选择的治疗方案用于亚洲人群复发性或转移性头颈部鳞状细胞癌的随机III期临床试验(CheckMate 141)的两年随访
Head Neck. 2020 Oct;42(10):2852-2862. doi: 10.1002/hed.26331. Epub 2020 Jun 24.
2
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.帕博利珠单抗治疗复发性/转移性头颈部鳞状细胞癌的疗效和安全性:KEYNOTE-012 长期随访后的汇总分析。
Br J Cancer. 2018 Jul;119(2):153-159. doi: 10.1038/s41416-018-0131-9. Epub 2018 Jun 29.
3
探讨BCAS3在头颈部鳞状细胞癌中的表达及其与预后的关系。
Cureus. 2023 Dec 23;15(12):e50995. doi: 10.7759/cureus.50995. eCollection 2023 Dec.
4
Retracted: The Immune Infiltration in HNSCC and Its Clinical Value: A Comprehensive Study Based on the TCGA and GEO Databases.撤回:头颈部鳞状细胞癌中的免疫浸润及其临床价值:基于TCGA和GEO数据库的综合研究。
Comput Math Methods Med. 2023 Dec 6;2023:9825043. doi: 10.1155/2023/9825043. eCollection 2023.
5
Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma.PNMA1表达的改变与头颈部鳞状细胞癌的不良预后和肿瘤免疫浸润相关。
J Oral Biol Craniofac Res. 2024 Jan-Feb;14(1):1-7. doi: 10.1016/j.jobcr.2023.11.003. Epub 2023 Dec 3.
6
Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma.免疫细胞反卷积揭示γδ T细胞与头颈部鳞状细胞癌患者生存率低可能存在关联。
Cancers (Basel). 2023 Oct 5;15(19):4855. doi: 10.3390/cancers15194855.
7
SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.SLA2 是 HNSCC 的预后标志物,与肿瘤微环境中的免疫细胞浸润相关。
Eur Arch Otorhinolaryngol. 2024 Jan;281(1):427-440. doi: 10.1007/s00405-023-08213-4. Epub 2023 Sep 9.
8
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).靶向HER1(表皮生长因子受体)的嵌合抗原受体自然杀伤细胞对头颈鳞状细胞癌显示出高效的抗肿瘤活性。
Cancers (Basel). 2023 Jun 13;15(12):3169. doi: 10.3390/cancers15123169.
9
The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.B7/CD28 免疫调节剂的一致破坏预测口腔癌的预后。
Int J Mol Sci. 2023 Mar 21;24(6):5931. doi: 10.3390/ijms24065931.
10
A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients.一个功能丧失的多态性降低了头颈部癌患者的治疗效果。
Oncoimmunology. 2022 Apr 17;11(1):2059878. doi: 10.1080/2162402X.2022.2059878. eCollection 2022.
Understanding the tumor immune microenvironment (TIME) for effective therapy.理解肿瘤免疫微环境(TIME)以实现有效的治疗。
Nat Med. 2018 May;24(5):541-550. doi: 10.1038/s41591-018-0014-x. Epub 2018 Apr 23.
4
Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study.头颈部鳞状细胞癌中的免疫细胞浸润与患者预后:一项回顾性研究。
Acta Oncol. 2018 Sep;57(9):1165-1172. doi: 10.1080/0284186X.2018.1445287. Epub 2018 Mar 1.
5
Profiling Tumor Infiltrating Immune Cells with CIBERSORT.使用CIBERSORT分析肿瘤浸润免疫细胞
Methods Mol Biol. 2018;1711:243-259. doi: 10.1007/978-1-4939-7493-1_12.
6
TCGA-assembler 2: software pipeline for retrieval and processing of TCGA/CPTAC data.TCGA汇编器2:用于检索和处理TCGA/CPTAC数据的软件管道
Bioinformatics. 2018 May 1;34(9):1615-1617. doi: 10.1093/bioinformatics/btx812.
7
The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.肿瘤浸润性T淋巴细胞在头颈部鳞状细胞癌中的预后作用:一项系统评价和荟萃分析。
Oncoimmunology. 2017 Aug 9;6(11):e1356148. doi: 10.1080/2162402X.2017.1356148. eCollection 2017.
8
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.肺癌中肿瘤浸润免疫细胞和免疫调节剂的预后全景。
Biomed Pharmacother. 2017 Nov;95:55-61. doi: 10.1016/j.biopha.2017.08.003. Epub 2017 Aug 18.
9
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.帕博利珠单抗治疗铂类和西妥昔单抗难治性头颈癌:一项单臂II期研究的结果
J Clin Oncol. 2017 May 10;35(14):1542-1549. doi: 10.1200/JCO.2016.70.1524. Epub 2017 Mar 22.
10
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.乳腺癌免疫浸润模式及其临床意义:一项基于基因表达的回顾性研究。
PLoS Med. 2016 Dec 13;13(12):e1002194. doi: 10.1371/journal.pmed.1002194. eCollection 2016 Dec.